Igm Biosciences Stock Market Value
| IGMS Stock | USD 8.89 0.88 9.01% |
| Symbol | IGM |
IGM Biosciences Price To Book Ratio
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of IGM Biosciences. If investors know IGM will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about IGM Biosciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (3.61) | Revenue Per Share 0.048 | Quarterly Revenue Growth 0.014 | Return On Assets (0.37) | Return On Equity (1.32) |
The market value of IGM Biosciences is measured differently than its book value, which is the value of IGM that is recorded on the company's balance sheet. Investors also form their own opinion of IGM Biosciences' value that differs from its market value or its book value, called intrinsic value, which is IGM Biosciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because IGM Biosciences' market value can be influenced by many factors that don't directly affect IGM Biosciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between IGM Biosciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if IGM Biosciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, IGM Biosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
IGM Biosciences 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to IGM Biosciences' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of IGM Biosciences.
| 10/24/2024 |
| 11/23/2024 |
If you would invest 0.00 in IGM Biosciences on October 24, 2024 and sell it all today you would earn a total of 0.00 from holding IGM Biosciences or generate 0.0% return on investment in IGM Biosciences over 30 days. IGM Biosciences is related to or competes with Avidity Biosciences, Cullinan Oncology, Mineralys Therapeutics,, Monte Rosa, Design Therapeutics, Werewolf Therapeutics, and Ikena Oncology. IGM Biosciences, Inc., a biotechnology company, develops Immunoglobulin M antibodies for the treatment of cancer, infect... More
IGM Biosciences Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure IGM Biosciences' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess IGM Biosciences upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.02) | |||
| Maximum Drawdown | 41.11 | |||
| Value At Risk | (9.42) | |||
| Potential Upside | 11.62 |
IGM Biosciences Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for IGM Biosciences' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as IGM Biosciences' standard deviation. In reality, there are many statistical measures that can use IGM Biosciences historical prices to predict the future IGM Biosciences' volatility.| Risk Adjusted Performance | 0.0034 | |||
| Jensen Alpha | (0.26) | |||
| Total Risk Alpha | (1.01) | |||
| Treynor Ratio | (0.03) |
IGM Biosciences Backtested Returns
Currently, IGM Biosciences is slightly risky. IGM Biosciences holds Efficiency (Sharpe) Ratio of 0.0039, which attests that the entity had a 0.0039% return per unit of volatility over the last 3 months. We have found twenty-four technical indicators for IGM Biosciences, which you can use to evaluate the volatility of the firm. Please check out IGM Biosciences' risk adjusted performance of 0.0034, and Market Risk Adjusted Performance of (0.02) to validate if the risk estimate we provide is consistent with the expected return of 0.0287%. The company retains a Market Volatility (i.e., Beta) of 1.94, which attests to a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, IGM Biosciences will likely underperform. IGM Biosciences now retains a risk of 7.36%. Please check out IGM Biosciences potential upside, as well as the relationship between the rate of daily change and period momentum indicator , to decide if IGM Biosciences will be following its current trending patterns.
Auto-correlation | 0.43 |
Average predictability
IGM Biosciences has average predictability. Overlapping area represents the amount of predictability between IGM Biosciences time series from 24th of October 2024 to 8th of November 2024 and 8th of November 2024 to 23rd of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of IGM Biosciences price movement. The serial correlation of 0.43 indicates that just about 43.0% of current IGM Biosciences price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.43 | |
| Spearman Rank Test | 0.58 | |
| Residual Average | 0.0 | |
| Price Variance | 2.05 |
IGM Biosciences lagged returns against current returns
Autocorrelation, which is IGM Biosciences stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting IGM Biosciences' stock expected returns. We can calculate the autocorrelation of IGM Biosciences returns to help us make a trade decision. For example, suppose you find that IGM Biosciences has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
IGM Biosciences regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If IGM Biosciences stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if IGM Biosciences stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in IGM Biosciences stock over time.
Current vs Lagged Prices |
| Timeline |
IGM Biosciences Lagged Returns
When evaluating IGM Biosciences' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of IGM Biosciences stock have on its future price. IGM Biosciences autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, IGM Biosciences autocorrelation shows the relationship between IGM Biosciences stock current value and its past values and can show if there is a momentum factor associated with investing in IGM Biosciences.
Regressed Prices |
| Timeline |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for IGM Stock Analysis
When running IGM Biosciences' price analysis, check to measure IGM Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy IGM Biosciences is operating at the current time. Most of IGM Biosciences' value examination focuses on studying past and present price action to predict the probability of IGM Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move IGM Biosciences' price. Additionally, you may evaluate how the addition of IGM Biosciences to your portfolios can decrease your overall portfolio volatility.